temozolomide has been researched along with arginyl-glycyl-aspartic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, N; Hide, T; Hirayama, M; Kobayashi, D; Komohara, Y; Kuratsu, J; Makino, K; Midorikawa, U; Mizuguchi, S; Nagai, M; Nagayama, M; Nakamura, H; Niibori-Nambu, A; Takeya, M; Takezaki, T; Tsubota, N | 1 |
| Akasov, R; Burov, S; Chiper, M; Dontenwill, M; Leko, M; Markvicheva, E; Vandamme, T; Zaytseva-Zotova, D | 1 |
| Gao, Z; Lai, X; Mao, G; Xiao, X; Zhang, J; Zhu, J; Zhu, X | 1 |
| Merabtene, F; Nataf, V; Prignon, A; Provost, C; Rozenblum-Beddok, L; Talbot, JN | 1 |
| Bierman, RD; Ehsanipour, A; Liang, J; Liu, S; Nathanson, DA; Seidlits, SK; Sohrabi, A; Wang, S; Xiao, W; Yu, Q; Zhang, R | 1 |
5 other study(ies) available for temozolomide and arginyl-glycyl-aspartic acid
| Article | Year |
|---|---|
Glioma initiating cells form a differentiation niche via the induction of extracellular matrices and integrin αV.
Topics: Animals; Brain Neoplasms; Carcinogenesis; Cell Adhesion; Cell Differentiation; Cell Movement; Cell Survival; Dacarbazine; Disease Progression; Extracellular Matrix; Fibronectins; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Ontology; Glioma; Humans; Integrin alphaV; Mice; Neoplasm Proteins; Neoplastic Stem Cells; Oligopeptides; Proteomics; Reproducibility of Results; RNA, Messenger; Spheroids, Cellular; Survival Analysis; Temozolomide | 2013 |
Formation of multicellular tumor spheroids induced by cyclic RGD-peptides and use for anticancer drug testing in vitro.
Topics: Antineoplastic Agents; Cell Culture Techniques; Cell Line, Tumor; Chemistry, Pharmaceutical; Curcumin; Dacarbazine; Doxorubicin; Drug Screening Assays, Antitumor; HCT116 Cells; Hep G2 Cells; Humans; MCF-7 Cells; Oligopeptides; Peptides, Cyclic; Spheroids, Cellular; Temozolomide | 2016 |
Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Lactoferrin; Lipids; Mice, Inbred BALB C; Nanostructures; Neoplasms, Neuroepithelial; Oligopeptides; Temozolomide; Tissue Distribution; Vincristine; Xenograft Model Antitumor Assays | 2018 |
[
Topics: Animals; Bevacizumab; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glioblastoma; Humans; Mice; Oligopeptides; Positron-Emission Tomography; Temozolomide; Tissue Distribution; Treatment Outcome; Tumor Burden | 2019 |
Bioengineered scaffolds for 3D culture demonstrate extracellular matrix-mediated mechanisms of chemotherapy resistance in glioblastoma.
Topics: Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; Extracellular Matrix; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Hyaluronan Receptors; Hyaluronic Acid; Integrin alphaV; Models, Biological; Oligopeptides; Temozolomide; Tissue Scaffolds; Tumor Microenvironment | 2020 |